FDA approves Pfizer drug for advanced breast cancer Medical Dialogues Bureau19 Oct 2018 9:20 AM ISTZurich: The U.S. Food and Drug Administration said on Tuesday it approved Pfizer Inc’s drug for an advanced form of breast cancer tied to an inherited...
Alembic Pharma gets USFDA nod for diabetes drug Alogliptin Medical Dialogues Bureau18 Oct 2018 12:12 PM ISTNew Delhi: Drug firm Alembic Pharmaceuticals Tuesday said it has received tentative nod from the US health regulator for its Alogliptin tablets used...
Multiple sclerosis drug: US court invalidates Teva's patent; boost for Natco, Mylan Medical Dialogues Bureau18 Oct 2018 11:50 AM ISTCopaxone is the most prescribed for relapsing forms of MS in the U.S., with brand sales for the 20 mg/ml dose at approximately $527 million and about...
Bengaluru: Mylan Hackathon 2018 Winners announced Medical Dialogues Bureau18 Oct 2018 11:18 AM ISTBENGALURU: Mylan Pharmaceuticals Private Limited announced the winners of its second edition of the Mylan Hackathon held in Bengaluru. The two-day...
Cost of blood pressure drug surges in U.S. after recall Medical Dialogues Bureau18 Oct 2018 9:20 AM ISTNEW YORK (Reuters) - Prices for two dosages of the blood pressure drug valsartan rose more than any other drug in the United States in September,...
Sanofi, Regeneron say late-stage Dupixent trials show positive results in Asthma Treatment Medical Dialogues Bureau18 Oct 2018 9:14 AM ISTPARIS, (Reuters) - Drugmakers Sanofi and Regeneron said on Tuesday that they received positive results for their Dupixent product, which treats eczema...
Sanofi, Novo Nordisk Eli Lilly accused of deceptive drug pricing of Insulin Medical Dialogues Bureau17 Oct 2018 3:16 PM ISTUS : Minnesota's attorney general on Tuesday filed a lawsuit accusing drug manufacturers Sanofi SA, Novo Nordisk and Eli Lilly and Co of deceptively...
Alembic Pharma gets USFDA nod for diabetes drug Medical Dialogues Bureau17 Oct 2018 3:16 PM ISTDrug firm Alembic Pharmaceuticals on Tuesday said it has received a tentative nod from the US health regulator for its Alogliptin tablets used for the...
China fines pharma firm $1.3 billion in vaccine scandal Medical Dialogues Bureau17 Oct 2018 3:03 PM ISTBEIJING: Chinese authorities have slapped penalties totaling a whopping US$1.3 billion on a pharmaceutical company over a vaccine scandal that fuelled...
Johnson & Johnson profit beats, lifts forecast on cancer drug demand Medical Dialogues Bureau17 Oct 2018 9:10 AM ISTJohnson & Johnson reported slightly better-than-expected third quarter profit and raised its full-year forecast on Tuesday as increased demand for...
Sanofi, Regeneron say late-stage Dupixent trials show positive results Medical Dialogues Bureau16 Oct 2018 1:56 PM ISTPARIS: Drugmakers Sanofi and Regeneron said on Tuesday that they received positive results for their Dupixent product, which treats eczema and is seen...
Dr Reddy's finalises deal to sell Hyderabad API unit to Therapiva Medical Dialogues Bureau16 Oct 2018 1:46 PM ISTNew Delhi: Drug major Dr Reddy's Laboratories (DRL) Monday said it will sell its active pharmaceutical ingredient (API) business unit in Hyderabad to...
